Gangliocytoma
ORPHA:251937DiseaseAdolescent, Childhood, Infancy
Фенотипы (HPO)26
Очень частый (80–99%)1
HP:0003005Ganglioneuroma
Частый (30–79%)4
HP:0002315Headache
HP:0010302Spinal cord tumor
HP:0012377Hemianopia
HP:0100006Neoplasm of the central nervous system
Периодический (5–29%)15
HP:0000141Amenorrhea
HP:0000802Impotence
HP:0000845Elevated circulating growth hormone concentration
HP:0000975Hyperhidrosis
HP:0002363Abnormal brainstem morphology
HP:0002460Distal muscle weakness
HP:0002650Scoliosis
HP:0003401Paresthesia
HP:0005616Accelerated skeletal maturation
HP:0007359Focal-onset seizure
HP:0011749Adrenocorticotropic hormone excess
HP:0011761Pituitary null cell adenoma
HP:0012503Abnormality of the pituitary gland
HP:0030018Decreased female libido
HP:0040086Abnormal prolactin level
Очень редкий (1–4%)6
HP:0000726Dementia
HP:0001262Excessive daytime somnolence
HP:0001317Abnormal cerebellum morphology
HP:0002591Polyphagia
HP:0003396Syringomyelia
HP:0006767Pituitary prolactin cell adenoma
Эпидемиология1
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | <1 / 1 000 000 | — | Worldwide | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)